Archives of Clinical Infectious Diseases

Published by: Kowsar

Seroprevalence of Brucellosis in HIV-Infected Patients in Sanandaj, Iran

Mohammad Ali Rezaee 1 , Ahmad Rashidi 1 , Mohammad Ghaedi 1 , Ali Jalili 1 , Ali Pazoki 1 , Shahoo Menbari 2 and Mohammad Reza Rahmani 1 , *
Authors Information
1 Department of Immunology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, IR Iran
2 Department of Pathology and Medical Laboratory Sciences, Faculty of Para Medicine, Kurdistan University of Medical Sciences, Sanandaj, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: April 24, 2013, 8 (2); ee16989
  • Published Online: April 17, 2013
  • Article Type: Research Article
  • Received: October 7, 2012
  • Revised: January 15, 2013
  • Accepted: February 27, 2013
  • DOI: 10.5812/archcid.16989

To Cite: Rezaee M A, Rashidi A, Ghaedi M, Jalili A, Pazoki A, et al. Seroprevalence of Brucellosis in HIV-Infected Patients in Sanandaj, Iran, Arch Clin Infect Dis. 2013 ; 8(2):ee16989. doi: 10.5812/archcid.16989.

Copyright © 2013, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Colmenero Castillo JD, Cabrera Franquelo FP, Hernandez Marquez S, Reguera Iglesias JM, Pinedo Sanchez A, Castillo Clavero AM. [Socioeconomic effects of human brucellosis]. Rev Clin Esp. 1989; 185(9): 459-63[PubMed]
  • 2. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med. 2005; 352(22): 2325-36[DOI][PubMed]
  • 3. Mantur BG, Biradar MS, Bidri RC, Mulimani MS, Veerappa, Kariholu P, et al. Protean clinical manifestations and diagnostic challenges of human brucellosis in adults: 16 years' experience in an endemic area. J Med Microbiol. 2006; 55: 897-903[DOI][PubMed]
  • 4. Barroso Garcia P, Rodriguez-Contreras Pelayo R, Gil Extremera B, Maldonado Martin A, Guijarro Huertas G, Martin Salguero A, et al. [Study of 1,595 brucellosis cases in the Almeria province (1972-1998) based on epidemiological data from disease reporting]. Rev Clin Esp. 2002; 202(11): 577-82[PubMed]
  • 5. Ruiz-Mesa JD, Sanchez-Gonzalez J, Reguera JM, Martin L, Lopez-Palmero S, Colmenero JD. Rose Bengal test: diagnostic yield and use for the rapid diagnosis of human brucellosis in emergency departments in endemic areas. Clin Microbiol Infect. 2005; 11(3): 221-5[DOI][PubMed]
  • 6. Al Dahouk S, Tomaso H, Nockler K, Neubauer H, Frangoulidis D. Laboratory-based diagnosis of brucellosis--a review of the literature. Part II: serological tests for brucellosis. Clin Lab. 2003; 49(11-12): 577-89[PubMed]
  • 7. Mansoor N, Abel B, Scriba TJ, Hughes J, de Kock M, Tameris M, et al. Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life. Clin Immunol. 2009; 130(3): 280-9[DOI][PubMed]
  • 8. Ansari AA, Pattanapanyasat K, Pereira LE. Autoimmunity and HIV/simian immunodeficiency virus infection: A two edged sword. Hepatol Res. 2007; 37 Suppl 3-95[DOI][PubMed]
  • 9. Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infect Dis. 2007; 7(12): 775-86[DOI][PubMed]
  • 10. Meyer CN, Skinhoj P, Prag J. Bacteremia in HIV-positive and AIDS patients: incidence, species distribution, risk-factors, outcome, and influence of long-term prophylactic antibiotic treatment. Scand J Infect Dis. 1994; 26(6): 635-42[PubMed]
  • 11. Zhan Y, Kelso A, Cheers C. Differential activation of <italic>Brucella</italic>-reactive CD4+ T cells by <italic>Brucella</italic> infection or immunization with antigenic extracts. Infect Immun. 1995; 63(3): 969-75[PubMed]
  • 12. Skendros P, Pappas G, Boura P. Cell-mediated immunity in human brucellosis. Microbes Infect. 2011; 13(2): 134-42[DOI][PubMed]
  • 13. El-Atrouni W, Berbari E, Temesgen Z. HIV-associated opportunistic infections. Bacterial infections. J Med Liban. 2006; 54(2): 80-3[PubMed]
  • 14. Vrioni G, Pappas G, Priavali E, Gartzonika C, Levidiotou S. An eternal microbe: <italic>Brucella</italic> DNA load persists for years after clinical cure. Clin Infect Dis. 2008; 46(12)-6[DOI][PubMed]
  • 15. Hadadi A, Rasoulinejad M, HajiAbdolbaghi M, Mohraz M, Khashayar P. Clinical profile and management of brucellosis in Tehran - Iran. Acta Clin Belg. 2009; 64(1): 11-5[PubMed]
  • 16. Young EJ. Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature. Rev Infect Dis. 1991; 13(3): 359-72[PubMed]
  • 17. Araj GF. Human brucellosis: a classical infectious disease with persistent diagnostic challenges. Clin Lab Sci. 1999; 12(4): 207-12[PubMed]
  • 18. Fakhar M, Banimostafavi E, Motazedian MH, Asgari Q. Co-infection of Leishmania infantum and <italic>Brucella</italic> spp. in Iran. Comp Clin Pathol . 2009; 18(1): 93-4
  • 19. Rezaee MA, Rashidi A, Motaharinia Y, Hossaini W, Rahmani MR. Seroprevalence study of brucellosis among high-risk groups in comparison with other people of the population in Sanandaj (West of Iran). Afr J Microbiol Res. 2012; 6(9): 1985-9[DOI]
  • 20. Abdollahi A, Morteza A, Khalilzadeh O, Rasoulinejad M. Brucellosis serology in HIV-infected patients. Int J Infect Dis. 2010; 14(10)-6[DOI][PubMed]
  • 21. Moreno S, Ariza J, Espinosa FJ, Podzamczer D, Miro JM, Rivero A, et al. Brucellosis in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1998; 17(5): 319-26[PubMed]
  • 22. Akhvlediani T, Clark DV, Chubabria G, Zenaishvili O, Hepburn MJ. The changing pattern of human brucellosis: clinical manifestations, epidemiology, and treatment outcomes over three decades in Georgia. BMC Infect Dis. 2010; 10: 346[DOI][PubMed]
  • 23. Ramos TR, Pinheiro Junior JW, Moura Sobrinho PA, Santana VL, Guerra NR, de Melo LE, et al. Epidemiological aspects of an infection by <italic>Brucella</italic> abortus in risk occupational groups in the microregion of Araguaina, Tocantins. Braz J Infect Dis. 2008; 12(2): 133-8[PubMed]
  • 24. Araj GF, Azzam RA. Seroprevalence of <italic>brucella</italic> antibodies among persons in high-risk occupation in Lebanon. Epidemiol Infect. 1996; 117(2): 281-8[PubMed]
  • 25. Swai ES, Schoonman L. Human brucellosis: seroprevalence and risk factors related to high risk occupational groups in Tanga Municipality, Tanzania. Zoonoses Public Health. 2009; 56(4): 183-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments